AU5310898A - Release-controlled coated tablets - Google Patents

Release-controlled coated tablets

Info

Publication number
AU5310898A
AU5310898A AU53108/98A AU5310898A AU5310898A AU 5310898 A AU5310898 A AU 5310898A AU 53108/98 A AU53108/98 A AU 53108/98A AU 5310898 A AU5310898 A AU 5310898A AU 5310898 A AU5310898 A AU 5310898A
Authority
AU
Australia
Prior art keywords
release
coated tablets
controlled coated
controlled
tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU53108/98A
Inventor
Steen Pedersen
Annette Rommelmayer Larsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xellia Pharmaceuticals ApS
Original Assignee
Dumex Alpharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dumex Alpharma AS filed Critical Dumex Alpharma AS
Publication of AU5310898A publication Critical patent/AU5310898A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
AU53108/98A 1996-12-20 1997-12-18 Release-controlled coated tablets Abandoned AU5310898A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK145696 1996-12-20
DK1456/96 1996-12-20
PCT/DK1997/000582 WO1998027967A1 (en) 1996-12-20 1997-12-18 Release-controlled coated tablets

Publications (1)

Publication Number Publication Date
AU5310898A true AU5310898A (en) 1998-07-17

Family

ID=8105028

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53108/98A Abandoned AU5310898A (en) 1996-12-20 1997-12-18 Release-controlled coated tablets

Country Status (2)

Country Link
AU (1) AU5310898A (en)
WO (1) WO1998027967A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
KR20010069756A (en) * 2001-05-08 2001-07-25 유형선 Method for controlled release of acemetacin in the intestinal tract and more particularly in the colon
AU2002226955B2 (en) * 2001-11-23 2006-04-27 Allergan Pharmaceuticals International Limited Pharmaceutical dosage form with multiple coatings
CA2476201C (en) 2002-02-21 2009-09-01 Biovail Laboratories Incorporated Modified release formulations of at least one form of tramadol
US8323692B2 (en) 2002-02-21 2012-12-04 Valeant International Bermuda Controlled release dosage forms
US20040029959A1 (en) * 2002-08-08 2004-02-12 John Devane Isosorbide mononitrate compositions and methods of their use
US8168170B2 (en) 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
CA2607949C (en) 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Feline probiotic bifidobacteria
DK1880001T3 (en) 2005-05-31 2011-09-12 Iams Company Feline probiotic lactobacilli
CN101711158A (en) 2007-02-01 2010-05-19 爱默思公司 Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US20110172249A1 (en) 2008-09-03 2011-07-14 Takeda Pharmaceutical Company Limted Method for improving absorbability of preparation, and preparation having improved absorbability
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
GR1007237B (en) * 2009-12-07 2011-04-08 Uni-Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε Με Δ.Τ. Uni-Pharma Abee, New process for the production of a stable pharmaceutical composition of intestine-soluble acetylsalicylic acid tablets coated with gastro-resistant film
BR112012027782A2 (en) 2010-04-30 2016-08-02 Takeda Pharmaceutical enteric tablet
EA030433B1 (en) 2010-04-30 2018-08-31 Такеда Фармасьютикал Компани Лимитед Enteric tablet
KR20140048882A (en) * 2011-05-13 2014-04-24 이모셔널 브레인 비.브이. Drug delivery system
JP2012107058A (en) * 2012-02-27 2012-06-07 Warner Chilcott Co Llc Pharmaceutical dosage form with multiple coatings

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2471186A1 (en) * 1979-12-10 1981-06-19 Roussel Uclaf NEW COLIC DELITESCENCE TABLETS AND THEIR PREPARATION PROCESS
DE3403329A1 (en) * 1984-02-01 1985-08-01 Horst Dr. 4019 Monheim Zerbe PHARMACEUTICAL PRODUCT IN THE FORM OF PELLETS WITH CONTINUOUS, DELAYED DELIVERY OF ACTIVE SUBSTANCES
SE460945B (en) * 1987-01-15 1989-12-11 Lejus Medical Ab A MULTIPLE-UNIT DOS COMPOSITION OF FUROSEMID
IT1246382B (en) * 1990-04-17 1994-11-18 Eurand Int METHOD FOR THE TARGETED AND CONTROLLED DELIVERY OF DRUGS IN THE INTESTINE AND PARTICULARLY IN THE COLON
DE4313726A1 (en) * 1993-04-27 1994-11-03 Byk Nederland Bv Solid dosage form
JPH11501026A (en) * 1995-02-28 1999-01-26 アストラ・アクチエボラーグ Use of isosorbide-5-mononitrate

Also Published As

Publication number Publication date
WO1998027967A1 (en) 1998-07-02

Similar Documents

Publication Publication Date Title
AU5310898A (en) Release-controlled coated tablets
AU5443698A (en) Coated detergent tablet
AU5259398A (en) Hopper
AU5235796A (en) o-hydroxyphenyl-s-triazines
AU4780896A (en) Core-board
AU1030997A (en) Taphane
AU5443898A (en) Coated detergent tablet
AU7625098A (en) Coated detergent tablet
AU4996696A (en) 2-benzyl-3-arylbenzothiophenes
AU5147496A (en) Fucopeptides
AU7638596A (en) Rotary sprinkler
AU5593896A (en) Benzisothiazolyl-substituted aminomethylchromans
AU5500196A (en) Anti-transpirants
AU4382896A (en) Acetylimidazobenzodiazepines
AU1834097A (en) Shared counter
AU5108596A (en) Morphine-3-esters
AU687716B3 (en) Sprinkler
AU5013796A (en) Wireclamp
AU5107096A (en) Haemodialyser
AU4391997A (en) Tablet dispenser
AU2308097A (en) Rapid-release s1452 tablets
AU4569496A (en) Tetralinyl- and indanyl-ethylamides
AUPO433396A0 (en) Sprinkler
AU4831396A (en) Pyrazolotetracyclines
AU2609095A (en) Compartmentalizer